Kids' metabolism and antipsychotic medication study
Part of Hormones & metabolism, Mental health clinical trials.
This study looks at how antipsychotic medicines affect metabolism in children ages 5-17. It compares those with and without metabolic issues, and a group not taking these medicines, to understand how their bodies process energy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 5 and 17 years old
- You take antipsychotic medicine daily for at least 3 months and have a metabolic problem like high blood sugar or weight gain
- You take antipsychotic medicine daily for at least 3 months and do not have any metabolic problems
- You don't take antipsychotic medicine but have a metabolic problem like high blood sugar or weight gain
- You do not have a genetic condition that affects metabolism, an eating disorder, or take supplements or drugs that change how your body uses energy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how nutrition, inflammation, and metabolism are linked to ADHD in children and teens. It may help us understand the biological factors behind ADHD.
This study tests a new way to measure your metabolic health, which affects how your body uses energy. It may help you understand if your metabolism is working well or if you have risk factors for conditions like diabetes or heart disease.
This study looks at how children’s “energy use” relates to heart and metabolism health. It may help doctors understand what healthy and unhealthy patterns look like in kids.
This study evaluates children (and sometimes relatives) who may have hormone (endocrine) or metabolism-related conditions. It helps doctors better understand these problems by doing a clinical evaluation.
This study looks at how anxiety and metabolism are connected in anorexia nervosa. If you are a teen girl newly diagnosed and not yet treated, you may help us learn more about these links.
This trial looks at how a natural chemical pathway in the body might relate to thinking problems in people with schizophrenia. It compares healthy volunteers to people with schizophrenia to find biological clues.
Hear when a new Neurodevelopmental Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.